Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
IN BRIEF: Omega Diagnostics receives CD4 deferred consideration
Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Receives a deferred consideration of GBP4.0 million relating to the sale of its CD4 business.
In August, Omega sold its CD4-focused Global Health division for GBP6.1 million to Accubio Ltd, a wholly-owned subsidiary of Chinese biotechnology firm Zhejiang Orient Gene Biotech Co Ltd.
Current stock price: 4.08 pence, up 13% on Friday
12-month change: down 86%
By Abby Amoakuh; abbyamoakuh@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
Shares in this article
Latest News
- Prince Harry's wife Meghan and their children will not join him in London next week
11 hours ago - UK's Next plans takeover bid for Harvey Nichols, Sky News reports
12 hours ago - Burnham says no to calling UK election, but says wants voting reform
14 hours ago - Outgoing UK PM Starmer says successor cannot spend less time on foreign affairs
15 hours ago - UK's Next plans takeover bid for Harvey Nichols, Sky News reports
15 hours ago - Oil prices little changed as US-Iran peace efforts hold
1 day ago - IN BRIEF: Critical Metals agrees GBP2.5 million loan note facility
1 day ago
Related News
TRADING UPDATES: Solid State sees strong orders in security & defence
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
M Winkworth + 2 more shares
Halfords + 4 more shares
Omega Diagnostics finance director steps down with immediate effect
(Alliance News) - Omega Diagnostics Group PLC on Tuesday said that Group Finance Director Chris Lea has stepped down with immediate effect, as he is b...
Follow the stocks
